Cencora, Inc. logo
Cencora, Inc. (COR)
Compare

Cencora, Inc. (COR) Stock Price: $281.67+0.19 (+0.07%)

At close: Jun 12, 2026, 4:00 PM ET

The closing share price for Cencora, Inc. (COR) stock was $281.67 for Friday, June 12, 2026, up 0.07% on the day.

Longer view (total return, dividends reinvested): past 12 months -3.8% · 3-year avg +17.2%/yr · 5-year avg +19.9%/yr

COR Price Chart

End-of-day pricesAdvanced chart →
COR$281.67 -5.08%(1Y)as of Jun 12, 2026

COR Earnings Preview

Next Earnings Date

Aug 5, 2026

53 days away

EPS Estimate

4.37

Revenue Est.

$84.36B

Last Quarter Results

EPS

$4.75

vs Estimate

$4.73

Met

Revenue

$78.36B

vs Estimate

$81.09B

Missed

COR Analyst Ratings

Consensus Rating

Buy

Based on 12 analysts

Strong Buy
4
Buy
8
Hold
2
Sell
0
Strong Sell
0

Average Price Target

$350.58

+24.5% upside

Low

$280.00

Current

$281.67

High

$412.00

COR Analyst Estimates

Forward P/E: 14.22

Earnings Per Share (EPS) Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q4 2027$5.10$5.21$5.316
Q1 2028$5.49$5.62$5.724
Q2 2028$5.52$5.64$5.756
Q3 2028$5.84$5.97$6.084

Annual

PeriodLowAvgHigh# Analysts
FY 2027$19.30$19.81$20.258
FY 2028$20.06$21.98$24.543

Revenue Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q4 2027$93.06B$94.65B$96.05B3
Q1 2028$85.84B$87.31B$88.60B2
Q2 2028$93.36B$94.95B$96.35B2
Q3 2028$97.98B$99.66B$101.13B2

Annual

PeriodLowAvgHigh# Analysts
FY 2027$351.29B$356.81B$365.14B9
FY 2028$377.25B$378.79B$380.34B9

Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.

COR Competitors' Key Metrics

StockMarket CapClose PricePrice ChangeTTM Total Return5Y CAGR10Y CAGRCompare
1COR$54.80B$281.67+0.07%-3.81%+19.86%+17.22%
2BDX$52.98B$146.24-0.75%+9.25%-2.99%+2.80%vs COR
3REGN$63.06B$612.14+0.11%+17.95%+3.26%+5.19%vs COR
4HUM$45.53B$379.22+2.86%+64.02%-1.01%+8.24%vs COR
5IDXX$44.24B$560.88+0.53%+6.45%-0.82%+20.22%vs COR
6A$36.67B$129.84+0.22%+9.88%-1.34%+11.94%vs COR

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA
47,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch